BL-2401
| BL-2401 | |
|---|---|
| [[File:|frameless|220px|alt=|Chemical structure of BL-2401]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
BL-2401 is an investigational drug currently under development for the treatment of cancer. It is a small molecule inhibitor that targets specific pathways involved in tumor growth and metastasis. BL-2401 is being studied for its potential efficacy in various types of cancer, including breast cancer, lung cancer, and colorectal cancer.
Mechanism of Action
BL-2401 functions by inhibiting key signaling pathways that are often dysregulated in cancer cells. It specifically targets the PI3K/AKT/mTOR pathway, which is crucial for cell proliferation and survival. By blocking this pathway, BL-2401 aims to reduce tumor growth and induce apoptosis in cancer cells.
Clinical Trials
BL-2401 is currently in the early stages of clinical trials. Phase I trials are focused on determining the safety, tolerability, and optimal dosing of the drug. Preliminary results have shown promise, with some patients experiencing a reduction in tumor size and progression.
Pharmacokinetics
The pharmacokinetic profile of BL-2401 is characterized by its oral bioavailability and moderate half-life, allowing for convenient dosing schedules. The drug is metabolized primarily in the liver and excreted through the kidneys.
Side Effects
Common side effects observed in clinical trials include nausea, fatigue, and mild gastrointestinal disturbances. More serious adverse effects are rare but may include liver enzyme elevation and hematological abnormalities.
Research and Development
BL-2401 is being developed by BioLineRx, a biopharmaceutical company specializing in oncology and immunology. The development of BL-2401 is part of a broader effort to create targeted therapies that offer improved outcomes for cancer patients.
Also see
| Oncology | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This oncology-related article is a stub.
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
